Looks like they gave up to much unless they have some data from the Phase II trials for other applications in there back pockets. If not looks like they would have been better off throwing themselves at the mercy of the court. What gets me thinking is that DNA is offering to pick up a lot of the tab for future applications of the drug and trials. All MHO though.
News 
Market Data 
Discover 
AI
